Elite Diagnostic Limited (JMSE:ELITE)

Market Cap	533.63M
Revenue (ttm)	853.82M
Net Income (ttm)	22.52M
Shares Out	353.40M
EPS (ttm)	0.06
PE Ratio	23.70
Forward PE	n/a
Dividend	0.01 (0.63%)
Ex-Dividend Date	Sep 19, 2025

Volume	30,798
Average Volume	34,253
Open	n/a
Previous Close	1.590
Day's Range	1.510 - 1.510
52-Week Range	1.450 - 2.620
Beta	-0.25
RSI	44.14
Earnings Date	Aug 13, 2025

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company offers CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It provides radiology procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In 2025, Elite Diagnostic's revenue was 853.82 million, an increase of 3.96% compared to the previous year's 821.28 million. Earnings were 22.52 million, a decrease of -13.90%.